ZA86446B - Canine parvovirus vaccines - Google Patents
Canine parvovirus vaccinesInfo
- Publication number
- ZA86446B ZA86446B ZA86446A ZA86446A ZA86446B ZA 86446 B ZA86446 B ZA 86446B ZA 86446 A ZA86446 A ZA 86446A ZA 86446 A ZA86446 A ZA 86446A ZA 86446 B ZA86446 B ZA 86446B
- Authority
- ZA
- South Africa
- Prior art keywords
- canine parvovirus
- pups
- parvovirus vaccines
- maternally derived
- vaccines
- Prior art date
Links
- 241000701931 Canine parvovirus Species 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 230000002085 persistent effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858502399A GB8502399D0 (en) | 1985-01-31 | 1985-01-31 | Canine parvovirus vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA86446B true ZA86446B (en) | 1986-09-24 |
Family
ID=10573707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA86446A ZA86446B (en) | 1985-01-31 | 1986-01-21 | Canine parvovirus vaccines |
Country Status (16)
Country | Link |
---|---|
US (2) | US4810494A (xx) |
EP (1) | EP0189958B1 (xx) |
JP (1) | JPH07112982B2 (xx) |
CN (1) | CN1022801C (xx) |
AT (1) | ATE47524T1 (xx) |
AU (1) | AU592786B2 (xx) |
CA (1) | CA1278513C (xx) |
DE (1) | DE3666529D1 (xx) |
DK (1) | DK162421C (xx) |
ES (1) | ES8706030A1 (xx) |
FI (1) | FI85222C (xx) |
GB (1) | GB8502399D0 (xx) |
IE (1) | IE58357B1 (xx) |
IL (1) | IL77694A (xx) |
NZ (1) | NZ214984A (xx) |
ZA (1) | ZA86446B (xx) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8502399D0 (en) * | 1985-01-31 | 1985-03-06 | Akzo Nv | Canine parvovirus vaccines |
IE60950B1 (en) * | 1987-09-28 | 1994-09-07 | Beecham Inc | Inactivation of viruses and bacteria |
AU633349B2 (en) * | 1989-08-08 | 1993-01-28 | Fort Dodge Australia Pty Limited | Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs |
DK0485463T3 (da) * | 1989-08-08 | 1995-11-27 | Webster Arthur Pty Ltd | Svækket hundeparvovirus (CPV), vaccine omfattende CPV og fremgangsmåde til forebyggelse af CPV-infektion i hunde |
US5885585A (en) * | 1994-11-08 | 1999-03-23 | Cornell Research Foundation, Inc. | Attenuated canine parvovirus vaccine |
US5814510A (en) * | 1994-11-08 | 1998-09-29 | Cornell Research Foundation, Inc. | Attenuated canine parvovirus vaccine |
US6063385A (en) * | 1997-11-07 | 2000-05-16 | Wisconsin Alumni Research Foundation | DNA vaccine for parvovirus |
PL378001A1 (pl) * | 2003-01-29 | 2006-02-20 | Pfizer Products Inc. | Szczepionki przeciw Bordetella bronchiseptica dla psów |
US20050266027A1 (en) * | 2004-05-25 | 2005-12-01 | Watson James B | Live organism product |
US8802171B2 (en) * | 2004-05-25 | 2014-08-12 | James B. Watson | Live organism product |
US8052971B2 (en) * | 2005-11-21 | 2011-11-08 | MG Biologics | Oral use of specific antibodies for intestinal health |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
MX2009013628A (es) * | 2007-06-14 | 2010-02-22 | Univ Oklahoma State | Vacunas que contienen variantes geneticas de parvovirus canino. |
US8227583B2 (en) * | 2007-06-14 | 2012-07-24 | The Board Of Regents For Oklahoma State University | Vaccines containing canine parvovirus genetic variants |
WO2011107534A1 (en) * | 2010-03-05 | 2011-09-09 | Intervet International B.V. | Recombinant attenuated parvovirus |
CN101942419B (zh) * | 2010-07-30 | 2012-08-22 | 中国农业科学院哈尔滨兽医研究所 | 犬细小病毒弱毒疫苗株及其应用 |
WO2012164372A1 (en) | 2011-06-01 | 2012-12-06 | Indian Immunologicals Limited | Recombinant anti-canine parvovirus antibody and uses thereof |
CN106591242B (zh) * | 2016-11-18 | 2019-08-30 | 北京世纪元亨动物防疫技术有限公司 | 一株犬细小病毒毒株cpv-yh及其应用 |
CN109735505A (zh) * | 2018-12-26 | 2019-05-10 | 河南农业大学 | 一株犬细小病毒毒株及其基因序列的扩增和应用 |
CN110859956B (zh) * | 2019-11-07 | 2020-11-20 | 衡阳师范学院 | 一种犬细小病毒灭活疫苗及其制备方法 |
CN113073083B (zh) * | 2020-01-03 | 2022-09-06 | 普莱柯生物工程股份有限公司 | 犬细小病毒弱毒株、及其制备的疫苗组合物和应用 |
CN117106732B (zh) * | 2023-09-07 | 2024-02-06 | 华中农业大学 | 一株犬细小病毒及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4193991A (en) * | 1978-12-20 | 1980-03-18 | Cornell Research Foundation, Inc. | Canine parvovirus vaccine |
US4303645A (en) * | 1980-04-18 | 1981-12-01 | Cornell Research Foundation, Inc. | Modified living canine parvovirus vaccine |
EP0117767A1 (en) * | 1983-01-07 | 1984-09-05 | Mgi Pharma, Inc. | Production of parvovirus subunit vaccines |
GB8502399D0 (en) * | 1985-01-31 | 1985-03-06 | Akzo Nv | Canine parvovirus vaccines |
-
1985
- 1985-01-31 GB GB858502399A patent/GB8502399D0/en active Pending
-
1986
- 1986-01-20 IE IE16886A patent/IE58357B1/en not_active IP Right Cessation
- 1986-01-21 AT AT86200088T patent/ATE47524T1/de not_active IP Right Cessation
- 1986-01-21 ZA ZA86446A patent/ZA86446B/xx unknown
- 1986-01-21 DE DE8686200088T patent/DE3666529D1/de not_active Expired
- 1986-01-21 EP EP86200088A patent/EP0189958B1/en not_active Expired
- 1986-01-23 IL IL77694A patent/IL77694A/xx not_active IP Right Cessation
- 1986-01-23 CA CA000500153A patent/CA1278513C/en not_active Expired - Lifetime
- 1986-01-28 US US06/823,333 patent/US4810494A/en not_active Expired - Lifetime
- 1986-01-29 CN CN86100726A patent/CN1022801C/zh not_active Expired - Lifetime
- 1986-01-29 AU AU52801/86A patent/AU592786B2/en not_active Expired
- 1986-01-30 NZ NZ214984A patent/NZ214984A/en unknown
- 1986-01-30 ES ES551461A patent/ES8706030A1/es not_active Expired
- 1986-01-30 JP JP61019162A patent/JPH07112982B2/ja not_active Expired - Fee Related
- 1986-01-30 FI FI860445A patent/FI85222C/fi not_active IP Right Cessation
- 1986-01-30 DK DK047286A patent/DK162421C/da not_active IP Right Cessation
-
1993
- 1993-02-25 US US08/025,713 patent/US5316764A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN86100726A (zh) | 1986-10-01 |
IL77694A (en) | 1992-06-21 |
ATE47524T1 (de) | 1989-11-15 |
JPS61180724A (ja) | 1986-08-13 |
CN1022801C (zh) | 1993-11-24 |
CA1278513C (en) | 1991-01-02 |
AU592786B2 (en) | 1990-01-25 |
JPH07112982B2 (ja) | 1995-12-06 |
IE860168L (en) | 1986-07-31 |
GB8502399D0 (en) | 1985-03-06 |
AU5280186A (en) | 1986-08-07 |
DK162421C (da) | 1992-03-23 |
DK47286A (da) | 1986-08-01 |
FI85222B (fi) | 1991-12-13 |
ES8706030A1 (es) | 1987-06-01 |
NZ214984A (en) | 1988-05-30 |
ES551461A0 (es) | 1987-06-01 |
EP0189958A3 (en) | 1988-07-06 |
DK47286D0 (da) | 1986-01-30 |
US4810494A (en) | 1989-03-07 |
IE58357B1 (en) | 1993-09-08 |
DE3666529D1 (en) | 1989-11-30 |
FI860445A (fi) | 1986-08-01 |
FI85222C (fi) | 1992-03-25 |
FI860445A0 (fi) | 1986-01-30 |
EP0189958A2 (en) | 1986-08-06 |
EP0189958B1 (en) | 1989-10-25 |
US5316764A (en) | 1994-05-31 |
DK162421B (da) | 1991-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3666529D1 (en) | Canine parvovirus vaccines | |
EP0090581A3 (en) | Small peptides with the specificity of foot and mouth disease viral antigens | |
ES8605039A1 (es) | Procedimiento para preparar una vacuna que comprende un derivado truncado, libre de una membrana de un tipo fijado a una membrana que tiene determinantes antigenicos expuestos. | |
EA199700272A1 (ru) | Вакцины, содержащие сапонин и стерин | |
ATE328068T1 (de) | Papillomavirus vakzine | |
IL107026A0 (en) | Antigen of hybrid m protein and carrier for group a streptococcal vaccine | |
EP0203676A3 (en) | Vaccine for generating an immunogenic t cell response protective against a virus | |
DK388384D0 (da) | Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse | |
GR1000470B (el) | Νεο στελεχος bacillus thuringiensis,μεθοδος απομονωσης των και σχετικες εντομοκτονες συνθεσεις. | |
ES2137310T3 (es) | Vacuna contra una infeccion por streptococcus suis. | |
ATE261314T1 (de) | P53 impfstoff | |
DK163062C (da) | Antigen, immunogen, proteinholdig vaccine imod coccidiose | |
IL97013A (en) | Immunoreactive protein of an eimeria merozoite surface antigen, dna encodidng it, the production of the protein and its use as a vaccine | |
DE3585578D1 (de) | Hepatitisoberflaechenantigenpartikelvakzin. | |
EP0050154A4 (en) | MODIFIED LIVING CANINE PARVOVIRUS VACCINE. | |
EP0193585A4 (en) | CROSS-REACTIVE AND PROTECTIVE EPITOPE OF CIRCUMSPOROZOIT PROTEINS. | |
ES2070846T3 (es) | Arn-virus sin reversion. | |
GR1000457B (el) | Νεες ενωσεις. | |
EP0344211A4 (en) | MONOCLONAL ANTIBODIES IN VACCINE COMPOSITIONS. | |
ATE159758T1 (de) | Azelluläre impfstoffe | |
GR3018670T3 (en) | Non-reverting RNA viruses | |
DK135686D0 (da) | Polypeptid med en antigen determinant af herpes simplex-virus, detsfremstilling og anvendelse |